Jul 24 2012 |
more articles from
|
Kuwait's NBK Cap Buys 50% of Turkey's Animal Drug Distributor Bavet
Tuesday, Jul 24, 2012
(This story was originally published Monday.)
DUBAI (Zawya Dow Jones)--Kuwait's NBK Capital, an investment and asset management unit of National Bank of Kuwait ( NBK .KW), said Monday it has acquired a 50% stake in Bavet, a Turkish distributor of animal pharmaceuticals.
NBK Capital, in an emailed statement, said that it acquired the stake through its NBK Capital Equity Partners Fund I, but didn't disclose the value of the deal or any other details.
NBK Capital said that the $250 million NBK Capital Equity Partners Fund, which it manages as part of its Alternative Investments Group, is a private equity fund. It added that this fund was set up for the acquisition of strategic stakes in growth companies in the Middle East and North Africa region.
Copyright (c) 2012 Dow Jones & Co.
(END) Dow Jones Newswires
24-07-12 0405GMT
© Copyright Zawya. All Rights Reserved.


Post Your Comment